Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × Peptides × Clear all

Phase

Status

Completed 12 Unknown 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Carboplatin 124 Cisplatin 123 Drug Therapy 102 Capecitabine 101 Bevacizumab 101 Oxaliplatin 100 Radiotherapy 89 Paclitaxel 89 Gemcitabine 86 tislelizumab 85 Cyclophosphamide 83 pembrolizumab 77 Specimen Handling 74 toripalimab 66 Injections 62 Fluorouracil 62 Magnetic Resonance Spectroscopy 59 sintilimab 55 Docetaxel 52 130-nm albumin-bound paclitaxel 51 Surgical Procedures, Operative 48 anlotinib 45 Biopsy 44 fludarabine 43 Pemetrexed 43 Leucovorin 42 lenvatinib 41 Standard of Care 41 Radiosurgery 40 venetoclax 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06195618 2025-06-25

TEBICA003 TNBC

Universidad Nacional de Colombia

Phase 1 Not yet recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡